Significance of Hepatitis B Recurrence in Liver Transplantation Recipients

Table 1

The clinical characteristics of the 48 patients with hepatitis B recurrence.

	Group A ()	Group B ()
Gender (M/F)	19/4	22/3	0.696
Age (years)			0.869
MELD			<0.001
Operation			0.106
Deceased donor	9	4
Living donor	14	21
Time to recurrence			0.051
Median (IQ)	10 (2-9)	13 (8.5-35)
Antiviral agents			0.632
Lamivudine	19	18
Entecavir	3	6
Tenofovir	1	1

M: male; F: female; MELD: model for end-stage liver disease; IQ: interquartile.